HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A successful liver transplantation for refractory hepatic veno-occlusive disease originating from cord blood transplantation.

Abstract
An 11-month-old boy with acute lymphoblastic leukemia (ALL) underwent umbilical cord blood transplantation (CBT) from an unrelated donor after a first complete remission. Despite the prophylactic use of low molecular weight heparin, prostaglandin E1 and ursodeoxycholic acid, hepatic veno-occlusive disease (VOD) occurred on the 29th day after CBT. Furthermore, neither defibrotide nor antithrombin-III improved the hepatic coma and coagulopathy due to the hepatic VOD. On the 42nd day after CBT, he underwent living related liver transplantation (LRLT) with a left lateral segment graft from his father. He received tacrolimus for the prevention of rejection and graft-vs.-host disease (GVHD) and also received aggressive antifungal and antiviral prophylaxis. Although he showed signs of acute rejection on postoperative days 5 and 10, the postoperative course was uneventful in general. At present, 17 months after LRLT, the patient shows stable liver function and no signs of either GVHD or a relapse of ALL. In conclusion, LRLT can be seen as a feasible option for the treatment of a hepatic VOD after CBT, though aggressive prophylaxis for infection and the anticipation of acute rejection are of importance.
AuthorsIl-Deok Kim, Hiroto Egawa, Yuhji Marui, Satoshi Kaihara, Hironori Haga, Ying-Wei Lin, Kazuko Kudoh, Tetsuya Kiuchi, Shinji Uemoto, Koichi Tanaka
JournalAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons (Am J Transplant) Vol. 2 Issue 8 Pg. 796-800 (Sep 2002) ISSN: 1600-6135 [Print] United States
PMID12243502 (Publication Type: Case Reports, Journal Article)
Topics
  • Cord Blood Stem Cell Transplantation (adverse effects)
  • Hepatic Veno-Occlusive Disease (etiology, surgery)
  • Humans
  • Infant
  • Liver (pathology)
  • Liver Transplantation
  • Male
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma (complications, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: